Universitas Diponegoro Holds Global Classroom on Liposome-Based Delivery System Innovation for Resistant Tuberculosis

Semarang, May 26, 2026 — Universitas Diponegoro once again strengthened its international academic network through the Undip Global Classroom (UGC) program held on Tuesday, May 26, 2026. The event featured an international speaker, Khairul Azfar Kamaruzaman, Ph.D. from Universiti Malaysia Sabah, who delivered a presentation entitled “Intervention against Resistant Tuberculosis: Modification of Liposome-Based Delivery System.”

The online international academic event was moderated by Prof. Dr. Dwi Hudiyanti, M.Sc., who also served as the person in charge of the program. The session was conducted interactively with the participation of lecturers, researchers, and students interested in drug delivery systems, nanotechnology, and liposome development for health applications.

In his presentation, Dr. Khairul Azfar Kamaruzaman explained recent developments in the modification of liposome-based delivery systems as an innovative strategy to improve the effectiveness of resistant tuberculosis therapy. Liposome technology is considered highly promising for enhancing drug stability, bioavailability, and targeted delivery, thereby supporting the development of safer and more effective therapeutic approaches.

Prof. Dwi Hudiyanti stated that the Global Classroom program reflects Universitas Diponegoro’s commitment to expanding international collaboration, fostering a global academic atmosphere, and strengthening multidisciplinary research development in biomaterials and active compound delivery systems.

The discussion session proceeded dynamically through an interactive question-and-answer segment covering opportunities for research collaboration, advances in liposome technology, and future challenges in addressing resistant tuberculosis. The program is expected to open further opportunities for academic and research collaboration between Universitas Diponegoro and Universiti Malaysia Sabah, particularly in biotechnology and nanotechnology-based drug delivery systems involving liposome applications.